A Financial Times Service
China Confidential - Premium Investment Insight

Best of Chinese Commentators

China’s toxic drug capsule scandal

19 April 2012

China’s drug regulator halted sales of 13 drugs on April 15 that use capsules allegedly made from industrial gelatin that contains excessive levels of toxic metal chromium, a potential cause of cancer. The 13 drugs under suspension were all made by Chinese pharmaceutical companies that buy plastic drug capsules produced by small manufacturers in China’s eastern Zhejiang province. The drug regulator also asked local authorities to carry out inspections of local capsule manufacturers. So far, police have reportedly detained 22 people who allegedly produced and sold the capsules.

RENMINBI COMPASS

Renminbi Compass Small Logo

Renminbi Compass, a new research service launched by the FT, aims to act as a navigational guide through the expanding universe of renminbi asset classes. With the Chinese currency gaining ever-wider acceptance around the world and Beijing taking steps to open its capital account, we are broadening our research coverage to include not only equity funds but also all other important renminbi asset classes, such as chengtou bonds, dim sum bonds, real estate, trust products, underground banking, art, antiques and several others.